People with HER2+/HR+ advanced breast cancer had the longest survival times — 42 months on average at the start and 53 months ...

New peer-reviewed study shows significant real-world improvement in pressure-ulcer healing with advanced cellular, acellular, and matrix-like products compared to standard care. MISSOULA, MT / ACCESS ...

People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the ...

SAN FRANCISCO (KGO) -- As we reported earlier this week, the Red Cross has declared a nationwide blood shortage crisis. Locally, blood collector Vitalant says that in the San Francisco Bay Area there ...

Izalontamab (SI-B001), a novel EGFR/HER3 bispecific monoclonal antibody, was well-tolerated and exhibited preliminary ...

Survey respondents with serious illness and those who were concerned about their surrogates’ decisions were more likely to have an advance care plan.

Aerobic and resistance exercise can significantly improve physical performance in patients living with metastatic breast ...

Patients traveling for cancer care face delays and advanced disease, but HIPEC treatment delivers strong long-term survival ...

Ola Landgren, MD, PhD, shares ADVANCE trial results, which show that adding daratumumab to carfilzomib-lenalidomide-dexamethasone (DKRd) improves outcomes in newly diagnosed multiple myeloma. Landgren ...

With heat waves among Europe's deadliest climate hazards, a team of scientists led by CMCC has developed a prediction system capable of providing helpful information four to seven weeks before summer, ...

Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non–Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial In this global phase III ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...